The Cleveland-based company plans to float approximately 16.2 million shares of common stock at $9.25 per share, bringing in $150 million gross before offering-related payments.
The offering, slated to close on August 17, will also include a 30-day underwriter’s option to purchase an additional 2.4 million shares at the same price.
ViewRay said it plans to use funds raised to support working capital and general corporate purposes, including R&D, clinical trials, capital expenditures and infrastructure expenses, according to a press release.
Late last month, ViewRay said that it tapped former Spectranetics head Scott Drake as its new chief executive officer and former Spectranetics COO Shar Matin as its new COO.
DeviceTalks Minnesota's leadership track is designed to provide attendees with insights on topics such as:
Use code SAVE15 to save 15%!